The best Bull and Bear pitches based on recency and number of recommendations.
Massive growth from sales of recently FDA approved drug Trogarzo.
There are no pitches that meet the Top Bear criteria. Explain
If this upsets you, start recommending pitches below!
Read the most recent pitches from players about THERF.
Recs
Massive growth from sales of recently FDA approved drug Trogarzo.
Recs
FDA approval of Tesamoralin passed. Hired management with track record to produce new product into the market place in late October 2010
Recs
This stock is trading near cash value. The main drug tesmorelin is proven to be effective at obesity reduction and positive health affects. It is in the III phase of testing and could receive priority processing from the FDA. The first FDA application is for aid patients and likely second application will be for the broader obesity market. The upside is massive. Current Valuation is $6.
Find the members with the highest scoring picks in THERF.
TSIF (99.99) Score: +144.34
I caught Theratechnologies on a short, but steep drop caused by safety concerns on its aids related drug. The drug did pass and THTCF is looking to list on the NASDAQ and go into production. 3/11
Top Pick |
Member Name |
Member Rating |
Start Date |
Call |
Time Frame |
Start Price |
Stock Gain |
Index Gain |
Score | Commentary |
---|---|---|---|---|---|---|---|---|---|---|
tyler1952 | < 20 | 8/15/2018 | 3Y | $6.78 | -44.10% | +85.24% | -129.34 | 0 Comment | ||
StoppedOut | < 20 | 5/29/2018 | 5Y | $10.92 | -65.29% | +93.51% | -158.80 | 1 Comment | ||
bigbonesmagoo | 26.07 | 10/18/2010 | 5Y | $4.60 | -17.62% | +344.26% | -361.87 | 0 Comment | ||
Munchenman77 | 50.63 | 12/3/2009 | 5Y | $3.56 | +6.46% | +368.91% | -362.45 | 0 Comment | ||
Fiscaldrone | 68.29 | 6/14/2010 | 5Y | $5.06 | -25.10% | +373.28% | -398.38 | 1 Comment | ||
GBPackerfanz | 54.19 | 9/2/2010 | 5Y | $4.70 | -19.36% | +380.32% | -399.68 | 0 Comment | ||
cmendress | < 20 | 5/7/2009 | 3Y | $2.33 | +63.01% | +473.81% | -410.80 | 1 Comment |
See what the Wall Street professionals think, according to their public statements and filings.